What is the difference between paroxysmal supraventricular tachycardia (PSVT) and supraventricular tachycardia (SVT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

PSVT vs SVT: Key Differences

PSVT (Paroxysmal Supraventricular Tachycardia) is a specific clinical subset of SVT (Supraventricular Tachycardia), not a different entity—PSVT refers to SVTs that start and stop abruptly, while SVT is the broader umbrella term encompassing all tachycardias originating from or above the His bundle. 1

Understanding the Terminology

SVT is the umbrella term that describes any tachycardia (heart rate >100 bpm at rest) where the mechanism involves tissue from the His bundle or above 1. This broad category includes:

  • Inappropriate sinus tachycardia
  • Atrial tachycardia (focal and multifocal)
  • Atrial flutter
  • Junctional tachycardia
  • AVNRT (atrioventricular nodal reentrant tachycardia)
  • AVRT (atrioventricular reentrant tachycardia via accessory pathways)

Importantly, SVT does not include atrial fibrillation, despite AF technically being supraventricular in origin 1.

What Makes PSVT Different

PSVT represents a clinical syndrome characterized by three defining features 1:

  1. Regular and rapid tachycardia (typically 150-250 bpm)
  2. Abrupt onset (sudden start)
  3. Abrupt termination (sudden stop)

These characteristics are most commonly seen in:

  • AVNRT (most common cause)
  • AVRT (second most common)
  • Atrial tachycardia (less frequently)

Clinical Distinction

The key difference is temporal pattern and presentation:

  • PSVT patients experience discrete episodes with sudden palpitations that start and stop abruptly 2, 3. They can often pinpoint the exact moment symptoms began and ended.

  • Other SVTs (like inappropriate sinus tachycardia, multifocal atrial tachycardia, or persistent atrial flutter) may have gradual onset, persistent patterns, or irregular rhythms that don't fit the paroxysmal pattern 1.

Epidemiology Clarification

The incidence of PSVT specifically is approximately 36 per 100,000 persons per year, with about 89,000 new cases annually in the US 1. Women have twice the risk of men, and individuals >65 years have >5 times the risk of younger persons 1, 4.

Why This Distinction Matters Clinically

The paroxysmal nature of PSVT makes it amenable to specific acute interventions that terminate reentrant circuits:

  • Vagal maneuvers are effective because they interrupt the reentrant circuit 3
  • Adenosine works specifically by blocking AV nodal conduction, breaking the circuit (91% effective) 3
  • Catheter ablation has exceptionally high success rates (94.3-98.5%) for PSVT because the reentrant circuits can be mapped and eliminated 3

In contrast, other SVTs like inappropriate sinus tachycardia or multifocal atrial tachycardia don't respond to these interventions because they don't involve reentrant mechanisms 1.

Common Pitfall to Avoid

Don't use "SVT" and "PSVT" interchangeably in documentation or communication. When you say "PSVT," you're specifically indicating a reentrant mechanism with abrupt onset/termination, which has different management implications than saying "SVT," which could include any supraventricular rhythm disturbance. This distinction affects treatment decisions, particularly regarding the appropriateness of catheter ablation as first-line therapy 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.